Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21707226 | 1.00 | BTK (0.83) | BTKEGFR | |
| SCHEMBL28536320 | 1.00 | BTK (0.83) | BTKEGFR | |
| SCHEMBL22442572 | 1.00 | BTK (0.83) | BTKEGFR | |
| SCHEMBL29948662 | 1.00 | BTK (0.83) | BTKEGFR | |
| SCHEMBL21706936 | 0.91 | BTK (1.00) | BTKEGFR | |
| SCHEMBL21707234 | 0.91 | BTK (1.00) | BTKEGFR | |
| SCHEMBL21707075 | 0.89 | BTK (1.00) | BTKEGFR | |
| SCHEMBL21707229 | 0.89 | BTK (0.85) | BTKEGFR | |
| SCHEMBL21707237 | 0.88 | BTK (1.00) | BTKEGFR | |
| SCHEMBL22222727 | 0.88 | BTK (1.00) | BTKEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116096369-B | Polymorphs of bruton's tyrosine kinase inhibitor, and preparation method and application thereof | 上海海雁医药科技有限公司 | 2025-09-16 | — | — | CN | disclosed |
| CN-116096369-A | Polymorphs of bruton's tyrosine kinase inhibitor, and preparation method and application thereof | 上海海雁医药科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-116096369-A | Polymorphs of bruton's tyrosine kinase inhibitor, and preparation method and application thereof | 上海海雁医药科技有限公司 | 2023-05-09 | — | — | CN | disclosed |
| CN-112334469-B | BTK inhibitor and pharmaceutically acceptable salt and polymorph thereof and application thereof | 上海海雁医药科技有限公司 | 2022-10-04 | — | — | CN | disclosed |
| CN-112334469-B | BTK inhibitor and pharmaceutically acceptable salt and polymorph thereof and application thereof | 上海海雁医药科技有限公司 | 2022-10-04 | — | — | CN | disclosed |